Authors: BARONE C CORSI DC POZZO C CASSANO A FONTANA T NOVIELLO MR LANDRISCINA M COLLOCA G ASTONE A

Citation: C. Barone et al., TREATMENT OF PATIENTS WITH ADVANCED GASTRIC-CARCINOMA WITH A 5-FLUOROURACIL-BASED OR A CISPLATIN-BASED REGIMEN - 2 PARALLEL RANDOMIZED PHASE-II STUDIES, Cancer, 82(8), 1998, pp. 1460-1467

Authors: POMPILI M RAPACCINI GL DELUCA F CATURELLI E ASTONE A SIENA DA VILLANI MR GRATTAGLIANO A CEDRONE A GASBARRINI G

Citation: M. Pompili et al., RISK-FACTORS FOR INTRAHEPATIC RECURRENCE OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS TREATED BY PERCUTANEOUS ETHANOL INJECTION, Cancer, 79(8), 1997, pp. 1501-1508

Authors: FLAMINI G CURIGLIANO G RATTO C ASTONE A FERRETTI G NUCERA P SOFO L SGAMBATO A BONINSEGNA A CRUCITTI F CITTADINI A

Citation: G. Flamini et al., PROGNOSTIC-SIGNIFICANCE OF CYTOPLASMIC P53 OVEREXPRESSION IN COLORECTAL-CANCER - AN IMMUNOHISTOCHEMICAL ANALYSIS, European journal of cancer, 32A(5), 1996, pp. 802-806

Authors: CASSANO A POZZO C CORSI CD FONTANA T NOVIELLO MR ASTONE A BARONE C

Citation: A. Cassano et al., EFFECT OF CISPLATIN IN ADVANCED COLORECTAL-CANCER RESISTANT TO 5-FLUOROURACIL PLUS (S)-LEUCOVORIN, Journal of cancer research and clinical oncology, 121(8), 1995, pp. 474-477

Authors: SGAMBATO A FLAMINI G ASTONE A CALVISI G VENTURA T DIGIESI G CITTADINI A

Citation: A. Sgambato et al., CLINICAL PREDICTIVE VALUE OF P53 AND C-ERBB-2 OVEREXPRESSION IN 54 PATIENTS WITH TRANSITIONAL-CELL CARCINOMA (TCC) OF THE URINARY-BLADDER, Journal of experimental & clinical cancer research, 13(4), 1994, pp. 323-330